Cannabidiol, or CBD, blocks the ability of lysophosphatidylinositol (LPI) to amplify neural signals in the hippocampus. LPI weakens the signals that counter seizures, further explaining the value of CBD to treat epilepsy.
State-level legalization of recreational cannabis does not increase substance use disorder or encourage the use of other illicit drugs, a new study of twins reveals. Additionally, legalized recreational cannabis can reduce alcohol consumption.
A new study seeks to better understand how cannabis use alters the oral microbiome and how this may have an impact on neurodegenerative disorders.
Study reveals almost one-third of chronic pain patients use cannabis to help manage their symptoms.
Since 2000, marijuana use in young adults has increased by 245%, while alcohol use in adolescents has seen a steady decline.
Study finds no evidence that cannabidiol (CBD) reduces the negative effects of cannabis.
Cannabis users experienced 14% more pain in the first 24 hours following surgery than non-cannabis users. Additionally, cannabis users consumed 7% more opioids post surgery.
Cannabis users show no difference in motivation for rewards, pleasure from rewards, or the brain's response to reward-seeking than non-cannabis users.
Prenatal exposure to cannabis was associated with an increased risk of neuropsychological disorders, including anxiety and depression, in children. The risk grows as they enter adolescence and adulthood.
Users of cannabis showed no difference in motivation, pleasure taken from rewards, or the brain's response to reward-seeking compared to non-cannabis users.
High-potency cannabis use is associated with an increased risk of addiction, cannabis use disorder, and mental health problems including an increased risk of schizophrenia, a new study reports.
Study reports adolescents are three times more likely to develop cannabis use disorder than adults, but may not be at more risk of developing other mental health disorders associated with cannabis use.
